During the past decade, Raymond Schaerf, MD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Raymond Schaerf, MD" are "Bradycardia" (2 trials), "Adverse Effect of MRI on an Implanted Pacemaker" (1 trials), "Adverse Effect of MRI on an Implanted Pacemaker Lead" (1 trials), "Cardiac Arrhythmia" (1 trials) and "Heart Disease" (1 trials). Many other conditions were trialed in "Raymond Schaerf, MD" in a lesser frequency.

Most popular intervention types in "Raymond Schaerf, MD" are "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Accent MRI system (lead safety)" (1 trials), "Accent MRI system (with MRI scan)" (1 trials), "Cardiac Rhythm Management device" (1 trials), "Pacemaker, ICD, or CRT device" (1 trials) and "St. Jude Medical Optisure Lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "Raymond Schaerf, MD" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Raymond Schaerf, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Raymond Schaerf, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Raymond Schaerf, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".